Citadel Advisors - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 149 filers reported holding NEWLINK GENETICS CORP in Q2 2015. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q4 2019$229,000
+43.1%
90,193
-10.2%
0.00%
Q3 2019$160,000
+56.9%
100,455
+45.7%
0.00%
Q2 2019$102,000
+7.4%
68,928
+40.6%
0.00%
Q1 2019$95,000
+46.2%
49,033
+16.8%
0.00%
Q4 2018$65,000
-79.0%
41,971
-67.6%
0.00%
Q3 2018$310,000
-70.4%
129,400
-41.3%
0.00%
Q2 2018$1,048,000
-21.1%
220,263
+20.2%
0.00%
Q1 2018$1,329,000
+7.6%
183,250
+20.3%
0.00%
Q4 2017$1,235,000
+29.5%
152,283
+62.5%
0.00%
Q3 2017$954,000
-43.6%
93,684
-59.3%
0.00%
-100.0%
Q2 2017$1,692,000
-32.6%
230,288
+121.1%
0.00%
-66.7%
Q1 2017$2,510,000
+548.6%
104,139
+176.2%
0.00%
Q4 2016$387,000
-63.4%
37,700
-46.4%
0.00%
-100.0%
Q3 2016$1,056,000
+1366.7%
70,300
+3436.2%
0.00%
Q4 2015$72,000
-96.3%
1,988
-96.4%
0.00%
-100.0%
Q3 2015$1,963,000
+1944.8%
54,768
+2426.2%
0.00%
Q2 2015$96,000
-98.2%
2,168
-97.7%
0.00%
-100.0%
Q1 2015$5,262,000
+470.1%
96,178
+314.1%
0.01%
+400.0%
Q4 2014$923,000
+823.0%
23,225
+398.2%
0.00%
Q3 2014$100,000
-63.1%
4,662
-51.2%
0.00%
Q1 2014$271,000
+31.6%
9,551
+1.9%
0.00%
Q4 2013$206,0009,3770.00%
Other shareholders
NEWLINK GENETICS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 93,533$962,0001.69%
WALL STREET ASSOCIATES 108,900$1,119,0000.74%
NORTHWEST WEALTH MANAGEMENT, LLC 57,482$591,0000.60%
Orbimed Advisors 1,991,700$20,475,0000.26%
TFS CAPITAL LLC 92,041$946,0000.25%
Intrinsic Edge Capital Management LLC 40,000$411,0000.18%
SECOR Capital Advisors, LP 100,529$1,033,0000.13%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 176,077$1,810,0000.12%
Piermont Capital Management Inc. 41,400$426,0000.10%
Vident Investment Advisory, LLC 67,209$691,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders